| KALA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the KALA shares outstanding history going back to 7/20/2017:
Also see: KALA Market Cap History KALA YTD Return |
KALA Shares Outstanding History — Kala Pharmaceuticals Share Count Over Time
As of 5/14/2026 Kala Pharmaceuticals has 18.59 million KALA shares outstanding. Investors often track the KALA shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows KALA share count trends over time, with 34 historical shares outstanding datapoints presented, dating back to 7/20/2017.
| KALA Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
KALA Historical Shares Outstanding: +136.64% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| KALA Stock Price Chart |
| About KALA BIO Inc |
| KALA BIO, Inc. is a clinical-stage biopharmaceutical company. Co. is engaged in the research, development and commercialization of therapies for rare and severe diseases of the eye. Co.'s biologics-based investigational therapies utilize its proprietary mesenchymal stem cell secretome (MSC-S) platform. Co.'s product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived bio factors, such as growth factors, protease inhibitors, matrix proteins and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. We show 34 historical shares outstanding datapoints in our coverage of KALA's shares outstanding history. Understanding the changing numbers of KALA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like KALA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching KALA by allowing them to research KALA shares outstanding history as well as any other stock in our coverage universe. |
| KALA Current Stock Quote |
Quotes delayed 20 minutes  Free KALA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| KALA Share Performance |
| Shares Outstanding Peers |
| Kala Pharmaceuticals (KALA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
KALV Shares Outstanding History KDMN Shares Outstanding History KDNY Shares Outstanding History KEQU Shares Outstanding History KERX Shares Outstanding History KIDS Shares Outstanding History KIN Shares Outstanding History KLDO Shares Outstanding History KLRS Shares Outstanding History KMPH Shares Outstanding History More Healthcare companies » |
KALA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
